XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows – Operating activities:    
Net earnings, including noncontrolling interests $ (13,679) $ 17,161
Adjustments to reconcile net earnings to net cash provided (used) by operating activities:    
Depreciation 20,148 21,522
Amortization of intangible and other assets 3,396 3,862
Loss on extinguishment of debt 0 7,610
Stock-based compensation 11,011 9,760
Foreign currency, asset write downs and other non-cash adjustments 6,893 24,260
Change in assets and liabilities:    
Accounts receivable, net 5,039 9,005
Inventories, net (48,715) (16,988)
Contract assets, net (5,655) (2,245)
Prepaid expenses and other assets, net (33,197) 307
Accounts payable 8,204 (47,093)
Contract liabilities 2,600 9,001
Accrued liabilities and income taxes payable 7,302 187
Retirement obligations and other 10,912 5,248
Net deferred taxes (1,032) (5,219)
Net cash flows provided (used) by operating activities (26,773) 36,378
Cash flows – Investing activities:    
Capital expenditures (14,052) (11,422)
Proceeds from disposal of assets and other 1,834 1,934
Net cash flows provided (used) by investing activities (12,218) (9,488)
Cash flows – Financing activities:    
Payments on senior notes 0 (407,473)
Payments on term loan (7,593) 0
Proceeds under other financing arrangements 555 425
Payments under other financing arrangements (484) (1,976)
Repurchases of common shares 0 (5,081)
Payments related to tax withholding for stock-based compensation (4,304) (5,547)
Payments of dividends (26,128) (26,465)
Other (437) (3,806)
Net cash flows provided (used) by financing activities (38,391) (449,923)
Effect of exchange rate changes on cash (5,275) (12,936)
Net change in cash and cash equivalents (82,657) (435,969)
Cash and cash equivalents at beginning of period 658,452 1,095,274
Cash and cash equivalents at end of period $ 575,795 $ 659,305